Zundler et al. showed that the core marker of intestinal TRM, CD69 and CD103, was significantly increased in IBD patients, and CD4 TRM was directly related to the recurrence of IBD; TRM depletion alleviates colitis by reducing inflammatory factors and lymphocyte infiltration [12]. The gene discussed is CD4; the disease is inflammatory bowel disease.